Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810785.RARi3COfm7bWs-axhB1CCoPxURzTTg-ocr12aCdf8omMA130_provenance.
• NP810792.RAYK-n2Y8zfKR2m7SotC0aFjooFgItVoqc3nLgZLLG9EA130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810792.RAYK-n2Y8zfKR2m7SotC0aFjooFgItVoqc3nLgZLLG9EA130_provenance.
• NP810794.RAep909bRXUe2F7MzR1ZOC4SKmNCs1rAntQYjfAg77t04130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810794.RAep909bRXUe2F7MzR1ZOC4SKmNCs1rAntQYjfAg77t04130_provenance.
• NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810790.RAiGWUwAOGt_WoE-lZ3NDeP8yuYmDykAgM_8e7-4tNDEM130_provenance.
• NP810793.RAh6hKa4268_pU_skRUCDYPwfkkyfW8tM7Qab_k7WNDqM130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810793.RAh6hKa4268_pU_skRUCDYPwfkkyfW8tM7Qab_k7WNDqM130_provenance.
• NP810787.RAIUUo62E-viF9tIHdjaK-_tG26KASvNNNLsGa9fAUCJ0130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810787.RAIUUo62E-viF9tIHdjaK-_tG26KASvNNNLsGa9fAUCJ0130_provenance.
• NP810789.RAL6gusaWkPTbYuFz97qPBpnYsRD5UeUoYAKMsPynRvtA130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810789.RAL6gusaWkPTbYuFz97qPBpnYsRD5UeUoYAKMsPynRvtA130_provenance.
• NP810791.RAJqze0u9Y87aQ879ui63QgAi4RqIU0xH1JV8id90kHlY130_assertion description "[We used a large panel of breast cancer cell lines and in vivo xenograft models to identify candidate predictive biomarkers for a selective inhibitor of class I PI3K that is currently in clinical development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810791.RAJqze0u9Y87aQ879ui63QgAi4RqIU0xH1JV8id90kHlY130_provenance.